P3

The Plant-Powered Production (P3) Center was funded by an NSF EPSCoR RII Track-1 award during 2010-2015.

The P3 Center (2010-2015) aimed to take advantage of the unique biosynthetic capacity of plants as scalable biofactories for proteins, chemicals, and biomaterials, critical to addressing global challenges in energy, human health, climate change and food security.

One startup company, BioStrategies, has received an additional $5.8M in NIH SBIR funding to commercialize their innovative therapies. The treatments are for metabolic diseases generally affecting children that are not being researched by the commercial pharmaceutical industry. Several of the P3 team continued the research through a Track-2 collaborative grant with Missouri researchers, the Plant Imaging Consortium.